Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Kushen extract (oxymatrine / matrine)

Oxymatrine / Matrine (Sophora Flavescens) · also known as Oxymatrine, Matrine, Kushen extract, Oxymatrine

Oxymatrine is an alkaloid from kushen. Animal and cell studies show it affects TGF-β1 and TLR4 signaling. In a randomized placebo-controlled trial at 900 mg/day, liver fibrosis scores improved in some re-assessed patients. That dose is higher than the 200–600 mg/day listed here.

Typical dose: High-purity oxymatrine 200–600 mg/day, taken with a meal. The oral liver fibrosis trial used 900 mg/day, so it does not directly show that 200–600 mg/day is effective. Safety data for long-term self-use are insufficient.
Absorption and forms: Oxymatrine has good water solubility, and after oral intake part of it can be converted to matrine by liver enzymes through deoxygenation. Oral absorption is incomplete. A rat pharmacokinetic study measured an absolute oral bioavailability of about 26%, and that figure cannot be taken directly as a human value.

Clinical uses and human evidence

Fatty liver and liver enzymes

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Song 2016 · Chin J Integr Med · Meta-analysis · n=5227 — Oral oxymatrine preparation for chronic hepatitis B: A systematic review of randomized controlled trials
  2. Lu 2003 · World J Gastroenterol · RCT · n=216 — Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial

Mechanisms of action

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★★☆☆Mechanism evidence: grade CSecondary target

In an animal cerebral ischemia model, oxymatrine downregulated TLR4, MyD88 and NF-κB-related expression in brain tissue. In cell experiments, nuclear translocation of p65 decreased. In mice, colitis was reduced, but the overall NF-κB reporter signal did not change. These results do not yet show that it strongly shuts off inflammatory transcription at usual oral doses in humans.

References (2)
  1. Fan 2009 · Rat cerebral ischemia model: oxymatrine downregulated TLR4, MyD88 and NF-κB-related expression in brain tissue.
  2. Rivera Guzman 2013 · Cell and mouse study: nuclear entry of p65 decreased in cells; colitis was reduced in mice, but the total NF-κB reporter signal did not change.

Collagen triple-helix cross-linking and fibril synthesis

★★☆☆☆Mechanism evidence: grade ASecondary target

In human oral trials, markers of collagen turnover fell, and only some participants had repeat biopsies. This does not mean that collagen cross-linking was promoted, and it does not prove that the Smad pathway is inhibited in humans. In studies using intravenous administration, serum TGF-β1 fell, but whether oral dosing suppresses Smad phosphorylation has not been directly confirmed.

References (2)
  1. Mao 2004 · Human randomized placebo-controlled trial: 900 mg/day orally; type III procollagen peptide improved, as did liver fibrosis scores in some patients who were re-assessed.
  2. Liang 2010 · Human randomized controlled study: serum TGF-β1 fell in the intravenous group; it was not directly shown that oral dosing suppresses Smad phosphorylation.

Mast cell membrane stabilization and degranulation blockade

★★☆☆☆Mechanism evidence: grade DSecondary target

In cell experiments, histamine and degranulation markers decreased in RBL-2H3 cells. Improvement in animal dermatitis alone also cannot prove that degranulation is blocked in vivo. It is not clear whether oral dosing reaches effective tissue exposure in humans, and eosinophils should not be treated as equivalent to mast cells.

References (1)
  1. Huang 2025 · Cell and guinea pig study: histamine and degranulation markers fell in RBL-2H3 cells; improvement in animal dermatitis alone cannot prove that degranulation is blocked in vivo.

Safety and drug interactions

Large doses may cause mild stomach discomfort or nausea, so take it with a meal. Strictly contraindicated in pregnancy. People taking drugs that inhibit central nervous system motor activity should follow medical advice. Safety data for long-term self-use are insufficient, and liver damage was also observed in high-dose animal experiments, so large doses should not be taken long-term without medical advice.
Open in the interactive app ›